Can an app ease the burden of genetic cancer risk for young adults?
NCT ID NCT06654466
First seen Nov 01, 2025 · Last updated May 08, 2026 · Updated 29 times
Summary
This study tests whether a software platform called Nest helps young adults (ages 18-49) who have a genetic risk for cancer better understand their risks and follow recommended screening. Participants will either use the platform or receive standard care. Researchers will compare knowledge, distress, and screening rates between the two groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CLINICAL DECISION SUPPORT are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dana Farber Cancer Institute
RECRUITINGBoston, Massachusetts, 02215, United States
Conditions
Explore the condition pages connected to this study.